Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po

Completed · Phase 4

Conditions studied: Healthy

In brief

This Phase IV study is intended to compare intragastric acid suppression of oral esomeprazole (NEXIUM ® Delayed-Release Capsules) with that of oral pantoprazole (PROTONIX ® Delayed Release Tablets ), in subjects who continue to require acid-suppressive therapy following a course of intravenous (iv) pantoprazole (PROTONIX ® I.V. for Injection).

Key facts

Study ID

NCT00206050

Run by

AstraZeneca

People needed

40

Starts

2004-09-01

Expected to finish

2004-12-01

Last updated by the study team

2011-01-21

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Provision of informed consent.
• Males and females aged 18 to 70 years, inclusive.
• Male or non-pregnant, nonlactating female healthy volunteer subjects. Females must be post-menopausal, surgically sterilized, or using a medically acceptable form of birth control, as determined by the investigator. Women of childbearing potential must agree to continue using an acceptable form of birth control throughout the conduct of the study.

You may not qualify if…

• Involvement in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the investigational site)
• Previous enrollment or randomization of treatment in the present study.
• Received an experimental drug or used an experimental device within 28 days preceeding the screening visit.

Where it is running

• Research Site — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.